16 October 2025Publication
Actualités clés en IP - Octobre 2025
Un aperçu de l’actualité marquante du dernier trimestre en matière de Propriété Intellectuelle.
Our clients trust us to handle their most important and complex technology transfer, licensing and collaboration arrangements.
Our technical backgrounds and industry experience put us in a unique position to handle collaborations and commercial arrangements involving cutting edge technologies and data monetisation. We have a firm grasp of complimentary disciplines including antitrust, regulatory and commercial law issues. And we will always draw on more specialist resources from across the firm when needed.
We advise on, prepare and negotiate agreements for a diverse group of clients including corporates, venture capital and private equity funds, financial institutions and governments, across a broad range of products and technologies.
We’re recognised for our expertise in the technology and life sciences sectors and act for some of the world’s largest biotechnology, pharmaceutical and electronics companies. Whatever the issue we will work with you to get the best result, every time.
Our core services include
- Agreements involving IP
- Confidential agreements
- Material transfer agreements
- Evaluation and feasibility agreements
- Research collaboration agreements
- Consortium agreements
- Grant agreements
- Licensing agreements
- Royalty monetisation agreements
- Clinical and commercial supply agreements
- Distribution agreements
- Co-promotion and co-marketing agreements
- Service agreements
Our experience
Investment fund
Our team advised on the formation of OGCI Climate Investments LLP, a $1bn collaborative investment fund designed to tackle climate change on a global scale, involving several of the world’s biggest oil and gas companies.
GSK Apollo Therapeutics
Advising on the £40m Apollo Therapeutics joint venture fund, a collaboration between GlaxoSmithKline, Johnson & Johnson Innovation and AstraZeneca with the technology transfer offices of Imperial College London, University College London and the University of Cambridge.
Mitsubishi UFJ
Advised Mitsubishi UFJ Trust and Banking Corporation on the IP aspects of a commercial agreement with Aberdeen Standard Investments, relating to the development and provision of a ground-breaking investment model employing artificial intelligence (AI), embedding machine learning techniques in the investment process. The innovative AI-model analyses variation patterns using factors such as value, volatility and quality and determines the applicable factor strategy by seeking similar patterns from historical records. A Global Equity fund adopting the investment model was launched by Aberdeen Standard Investments in Luxemburg in 2018.
Key contacts
If you have any questions, contact a member of the IP Licensing, Collaboration and Monetisation team for assistance:
Related insights
21 May 2020 Publication
Responsible contractual behaviour and litigation
What will be the impact of the government’s guidance for contractual parties in England on responsible behaviour in the COVID-19 crisis?
18 December 2019 Publication
The status of loot box regulation
In 2019, loot boxes came under their most intense scrutiny to date, with governments around the world taking increasing note. To stay on top of the regulations and self-regulatory practices that govern the implementation of loot boxes, and understand the additional challenges arriving in 2020, please see our Insight document covering the state of play in China, the UK, South Korea, Italy, Japan and the USA.
29 November 2019 Publication
An introduction to esports – Part 3
In the third part of a series of insights on legal considerations for esports, we speak with a former national level esports player about their experiences.
06 November 2019 Publication
An introduction to esports – Part 2
In a series of insights on legal considerations for esports, we tackle the most important legal issues for publishers, teams, sponsors and investors.